Literature DB >> 4017285

The splenic extraction ratio of antibody-coated erythrocytes and its response to plasma exchange and pulse methylprednisolone.

M J Walport, A M Peters, K B Elkon, C D Pusey, J P Lavender, G R Hughes.   

Abstract

Splenic blood flow was measured in a series of normal subjects and patients with connective tissue diseases by measuring the rate of equilibration and the partition of 111In-labelled autologous platelets between blood and spleen. These data were used to quantify the role of splenic blood flow in determining the splenic clearance of IgG coated erythrocytes (IgG-RBC) from the circulation. Previous studies have interpreted the clearance rates of IgG-RBC only in terms of splenic reticuloendothelial function. Splenic blood flow was increased in seven of eight patients with systemic lupus erythematosus (SLE), six of 10 patients with rheumatoid arthritis (RA) and in all five patients with essential mixed cryoglobulinaemia (EMC) compared with a series of thirteen normal subjects. Expressing the rate constant of clearance of IgG-RBC as a fraction of splenic blood flow gave a value for the 'extraction ratio' of IgG-RBC (a specific measurement of reticuloendothelial function, corrected for splenic blood flow). Normal splenic extraction ratio of IgG-RBC was calculated to be 32%. All the patients with SLE and with EMC had reduced extraction ratios (in seven out of 13 patients less than 10%). In RA the extraction ratio tended to be normal (average 27.3%) but variable (9-59%). Following plasma exchange in nine patients, a significant increase in IgG-RBC extraction ratio (average of 39% with respect to pre-exchange values, P less than 0.05) was found. In contrast there was no significant change in extraction ratio following pulse methylprednisolone therapy in a further nine patients. Although the rate constant of clearance of IgG-RBC decreased by an average of 33% (P less than 0.01) in the latter group, it was matched by an equal decrease of splenic blood flow (average 37%, P less than 0.01) and so extraction ratio showed no change. These data indicate that quantification of splenic reticuloendothelial function requires measurement of both IgG-RBC clearance and of splenic blood flow.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4017285      PMCID: PMC1577219     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Effect of cortisone on the disappearance kinetics and tissue localization of soluble immune complexes.

Authors:  A O Haakenstad; J B Case; M Mannik
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

Review 2.  NIH conference. Pathophysiology of immune hemolytic anemia.

Authors: 
Journal:  Ann Intern Med       Date:  1977-08       Impact factor: 25.391

3.  Saturation of the reticuloendothelial system with soluble immune complexes.

Authors:  A O Haakenstad; M Mannik
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

4.  Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes.

Authors:  J P Atkinson; A D Schreiber; M M Frank
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

5.  Splenic blood flow in cirrhosis and portal hypertension.

Authors:  R Williams; R E Condon; H S Williams; L M Blendis; L Kreel
Journal:  Clin Sci       Date:  1968-06       Impact factor: 6.124

6.  Spleen blood flow and splanchnic haemodynamics in blood dyscrasia and other splenomegalies.

Authors:  L M Blendis; D C Banks; C Ramboer; R Williams
Journal:  Clin Sci       Date:  1970-01       Impact factor: 6.124

7.  A simple and efficient method of labelling red cells with 99mTc for determination of red cell volume.

Authors:  J Jones; P L Mollison
Journal:  Br J Haematol       Date:  1978-01       Impact factor: 6.998

8.  Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome.

Authors:  C M Lockwood; A J Rees; T A Pearson; D J Evans; D K Peters; C B Wilson
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321

9.  Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.

Authors:  C J Jaffe; J M Vierling; E A Jones; T J Lawley; M M Frank
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

10.  Effects of corticosteroids on human monocyte function.

Authors:  J J Rinehart; S P Balcerzak; A L Sagone; A F LoBuglio
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  7 in total

Review 1.  The kidney in mixed cryoglobulinemias.

Authors:  D J Cordonnier; J C Renversez; P Vialtel; E Dechelette
Journal:  Springer Semin Immunopathol       Date:  1987

Review 2.  Complement deficiency and immune complex disease.

Authors:  K A Davies; J A Schifferli; M J Walport
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Mononuclear phagocyte system Fc-receptor function in patients with seropositive rheumatoid arthritis.

Authors:  S Lobatto; F C Breedveld; J A Camps; E K Pauwels; M L Westedt; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

4.  Effects of mannose and mannose derivatives on the clearance of IgG antibody-coated erythrocytes in the rat.

Authors:  M G Malaise; C Hoyoux; P Franchimont; J B Foidart; P R Mahieu
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

Review 5.  In vivo clearance by the mononuclear phagocyte system in humans: an overview of methods and their interpretation.

Authors:  C Halma; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

6.  Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies.

Authors:  K A Davies; A M Peters; H L Beynon; M J Walport
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 7.  Clearance of cryoglobulins in man.

Authors:  Y C Ng; J A Schifferli
Journal:  Springer Semin Immunopathol       Date:  1988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.